Drugs / Sodium Lauryl Sulfate
Sodium Lauryl Sulfate
also known as
SLS · E487 · NSC-402488 · Sodium dodecyl sulfate · Sodium laurilsulfate · Sodium lauryl sulfate, synthetic · Texapon k 12 p
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00680095 | Jan → Feb 2007 | tinea unguium | Pfizer | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00136643 | Jun 2005 → Jul 2007 | HIV infectious disease | Laval University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04531813 | Jun → Jul 2013 | hypersensitivity reaction disease | Bayer | Completed | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 1 | NCT03301870 Comparator | Oct → Nov 2017 | — | UNION therapeutics | Completed | No outcome recorded |
| Phase 1 | NCT02198963 Comparator | Jul → Aug 2014 | irritant dermatitis | Pulmatrix Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02169154 Comparator | Jun → Jul 2014 | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT02160574 Comparator | Jun → Sep 2014 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02061813 Background | Jan 2014 | Pediculus humanus capitis infestation | Dr. Reddy's Laboratories Limited | Completed | No outcome recorded |
| Phase 1 | NCT01984775 Comparator | Oct 2013 → Jul 2014 | psoriasis | Stiefel, a GSK Company | Completed | No outcome recorded |
| Phase 1 | NCT01821274 Comparator | Mar → Jul 2013 | irritant dermatitis | Ventrus Biosciences, Inc | Unknown | No outcome recorded |
| Phase 1 | NCT01816529 Comparator | Mar → Jun 2013 | — | Ventrus Biosciences, Inc | Unknown | No outcome recorded |
| Phase 1 | NCT01787448 Comparator | Jan → Feb 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01771822 Comparator | Jan → Feb 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01430312 Comparator | Sep → Dec 2011 | — | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Lauryl Sulfate | “A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance and Acceptability of a Vaginal Gel Containing Sodium Lauryl Sulfate (Invisible Condom®)...” NCT00136643 ↗13“Sodium Lauryl Sulfate 0.05% (w/v), USP in sterile, distilled Water for Injection, USP” NCT03301870 ↗ “Positive control contains sodium lauryl sulfate solution 0.1% (1 mg/g).” NCT01984775 ↗ “Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days” NCT00680095 ↗ |
| Known as | E487 | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Known as | NSC-402488 | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Known as | SLS | “a gel formulation containing sodium lauryl sulfate (SLS) (compared to gel alone and placebo) when applied intravaginally in healthy volunteers.” NCT00136643 ↗3“0.1% solution of sodium lauryl sulfate (SLS)” NCT01816529 ↗ “Positive Control-Sodium lauryl sulfate (SLS)” NCT04531813 ↗ “0.1% solution o sodium lauryl sulfate (SLS)” NCT01821274 ↗ |
| Known as | Sodium dodecyl sulfate | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Known as | Sodium laurilsulfate | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Known as | Sodium lauryl sulfate, synthetic | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Known as | Texapon k 12 p | ChEMBL registry synonym — accepted as the source's own label CHEMBL23393 ↗ |
| Modality | Small molecule | — CHEMBL23393 ↗ |
| Route | Topical | “will be patched on his/her back with AN2690 Solution 2.5%, AN2690 Solution 5%, AN2690 Solution 7.5%, AN2690 Solution Vehicle and Sodium Laurel Sulfate 0.5%” NCT00680095 ↗ |